On Friday, Following Stocks were among the “Top 100 Gainers” of U.S. Stock Market: Ctrip.com International Ltd. (NASDAQ:CTRP), Nxt-ID, Inc. (NASDAQ:NXTD), Vascular Biogenics Ltd. (NASDAQ:VBLT), Ecopetrol SA (NYSE:EC)
Ctrip.com International Ltd. (NASDAQ:CTRP), with shares skyrocketed 24.79%, closed at $57.58.
Nxt-ID, Inc. (NASDAQ:NXTD), with shares jumped 22.47%, settled at $3.87.
Vascular Biogenics Ltd. (NASDAQ:VBLT), with shares climbed 21.31%, and closed at $5.75.
Ecopetrol SA (NYSE:EC), surged 4.85%, and closed at $15.12.
Latest NEWS regarding these Stocks are depicted underneath:
Ctrip.com International Ltd. (NASDAQ:CTRP)
Ctrip.com International Ltd. (CTRP), a leading travel service provider of accommodation reservation, transportation ticketing, packaged tours and corporate travel administration in China, declared its unaudited financial results for the fourth quarter and the full year ended December 31, 2014.
Highlights for the Fourth Quarter of 2014:
- Net proceeds were RMB1.9 billion (US$308 million) for the fourth quarter of 2014, up 33% year-on-year, surpassing our net proceed guidance of 30% raise year-on-year for the fourth quarter 2014.
- Accommodation reservation volume raised 53% year-on-year, surpassing our guidance of 40-50% volume raise year-on-year, and accommodation reservation proceeds raised 31% year-on-year, reaching RMB842 million (US$136 million) for the fourth quarter of 2014.
- Transportation ticketing volume raised 102% year-on-year, surpassing our guidance of 55-65% volume raise year-on-year, and transportation ticketing proceeds raised 34% year-on-year, reaching RMB774 million (US$125 million) for the fourth quarter of 2014.
- Gross margin was 69% for the fourth quarter of 2014, contrast to 73% in the same period in 2013, and 72% in the previous quarter.
- Net Loss attributable to Ctrip’s shareholders was RMB224 million (US$36 million) for the fourth quarter of 2014, contrast to net revenue attributable to Ctrip’s shareholders of RMB261 million (US$43 million) in the same period in 2013. Not including share-based compensation charges (non-GAAP), net loss attributable to Ctrip’s shareholders was RMB98 million (US$16 million), contrast to net revenue attributable to Ctrip’s shareholders of RMB368 million (US$61 million) in the same period in 2013.
- Diluted earnings per ADS were RMB-1.60 (US$-0.26) for the fourth quarter of 2014. Not including share-based compensation charges (non-GAAP), diluted earnings per ADS were RMB-0.70 (US$-0.11) for the fourth quarter of 2014.
- Share-based compensation charges were RMB127 million (US$20 million), accounting for 7% of the net proceeds, or RMB0.90 (US$0.15) per ADS for the fourth quarter of 2014.
Highlights for the Full Year 2014:
- Net proceeds were RMB7.3 billion (US$1.2 billion) in 2014, up 36% year-on-year.
- Accommodation reservation volume raised 63% year-on-year, and accommodation reservation proceeds raised 45% year-on-year, reaching RMB3.2 billion (US$516 million) in 2014.
- Transportation ticketing volume raised 90% year-on-year, and transportation ticketing proceeds raised 36% year-on-year, reaching RMB3.0 billion (US$475 million) in 2014.
- Gross margin was 71% in 2014, contrast to 74% in 2013.
- Net revenue attributable to Ctrip’s shareholders was RMB243 million (US$39 million) in 2014, down 76% year-on-year. Not including share-based compensation charges (non-GAAP), net revenue attributable to Ctrip’s shareholders was RMB739 million (US$119 million), down 49% year-on-year.
- Diluted earnings per ADS were RMB1.59 (US$0.26) in 2014. Not including share-based compensation charges (non-GAAP), diluted earnings per ADS were RMB4.84 (US$0.78) in 2014.
- Share-based compensation charges were RMB497 million (US$80 million), accounting for 7% of the net proceeds, or RMB3.25 (US$0.52) per ADS in 2014.
Ctrip.com International, Ltd., together with its auxiliaries, provides travel services for hotel accommodations, ticketing services, packaged tours, and corporate travel administration in China.
Nxt-ID, Inc. (NASDAQ:NXTD)
Nxt-ID, Inc. (NXTD), declared its biometric payment technology, the Wocket® smart wallet was featured in a news clip that aired this week on Washington DC’s Fox 5 News.
In a segment “The Next Great Thing”, host Laura Evans calls the Wocket smart wallet ‘a new way to pay’ and ‘a really big breakthrough in mobile payment.’
Award-winning journalist Laura Evans has been part of the FOX 5 News Team since 1999.
She introduces the Wocket telling the audience that with over 13 million cases of identity theft annually and almost half of them due to a stolen or lost wallet, “Now there is a device that could take the pain and hassle out of that forever. ”
She goes on to say, “The Wocket is a convenient and universal form of payment that secures your personal information and that’s why we think the Wocket is the next great thing.”
CEO, Gino Pereira discusses and demonstrates how the Wocket works as your own personal vault, storing all your personal information securely.
Laura also shares her enthusiasm on two other innovative tech products on the segment; VFit, a new way to measure fitness and the Bolt Smart Lightbulb.
Laura Evans notes in closing that both the Wocket and Bolt created a lot of buzz at the Consumer Electronics (CES) show held in January 2015 in Las Vegas.
Nxt-ID, Inc., a technology corporation, provides various biometric solutions. The corporation develops Wocket, a physical electronic wallet that is intended to hold information from credit cards, identification cards, and virtually any magnetic stripe card to allow a specific owner of the card to configure a single electronic card to replicate any of the copied cards; MobileBio VoiceMatch, a method of recognizing speakers and specific words providing multi-factor recognition; and FaceMatch that is intended to serve as a modular facial recognition system for smartphones, tablets, laptop, and desktop computers.
Vascular Biogenics Ltd. (NASDAQ:VBLT)
Vascular Biogenics Ltd. (VBLT), a clinical-stage biotechnology corporation committed to the discovery, development and commercialization of first-in-class treatments for cancer, recently declared that it will host a conference call and live audio webcast on Wednesday, March 25, 2015 at 8:30 a.m. ET to report fourth quarter and full year 2014 financial results and talk about recent business activities.
To take part in the conference call, please dial 1-877-280-1254 (domestic) or +972-3-721-9510 (international) and refer to conference ID 9987278.
Vascular Biogenics Ltd., a clinical-stage biopharmaceutical corporation, is engaged in the discovery, development, and commercialization of treatments for cancer and immune-inflammatory diseases.
Ecopetrol SA (NYSE:EC)
Ecopetrol SA (EC), and Pacific Rubiales Energy declared that they have agreed not to extend the Rubiales risk participation and Piriri joint venture contracts that expire in 2016.
Ecopetrol will be examining different options for the operation of the Rubiales field. For its part, Pacific Rubiales Energy will explore the possibility of presenting a proposal to operate this asset.
Both Ecopetrol and Pacific Rubiales Energy have expressed interest in ongoing to develop business opportunities for the benefit of both parties and that of the country.
Ecopetrol S.A., an integrated oil corporation, is engaged in the exploration, development, and production of crude oil and natural gas primarily in Colombia, Peru, Brazil, and the United States Gulf Coast.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
